Condition
Schizoaffecitve Disorder
Total Trials
4
Recruiting
1
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (1)
P 1 (1)
P 2 (2)
Trial Status
Not Yet Recruiting2
Completed1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07434479Not ApplicableRecruiting
A Virtual Reality Mindfulness Application for Aggression in Schizophrenia
NCT07592169Phase 2Not Yet Recruiting
Confirmatory Trial of Gamma Neurofeedback to Improve Working Memory in Schizophrenia
NCT07423546Phase 1Not Yet Recruiting
A PET/MRI Study of Cobenfy on Dopamine Transmission in Schizophrenia
NCT00005658Phase 2Completed
Glycine to Treat Psychotic Disorders in Children
Showing all 4 trials